DirectSeq Biosciences, INC.

Biotechnology company · Schenectady, New York, United States

DirectSeq Biosciences, INC. is a biotechnology company headquartered in Schenectady, New York, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $621,588 in total, most recently in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

DirectSeq Biosciences at a glance

Typebiotechnology company

HeadquartersSchenectady, New York, United States

Employees (self-reported, 2024)3

What does DirectSeq Biosciences do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $621,588 in total (2024). NIH funding came from the National Human Genome Research Institute.

Frequently asked questions about DirectSeq Biosciences

Where is DirectSeq Biosciences headquartered?

DirectSeq Biosciences, INC. is headquartered in Schenectady, New York, United States.

What does DirectSeq Biosciences do?

DirectSeq Biosciences, INC. is a biotechnology company.

Similar companies

Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
Cognition Therapeutics IncPurchase, New York, United States
Agenus IncLexington, Massachusetts, United States
Vaxcyte, Inc.San Carlos, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences